Journals / Kocaeli Tıp Dergisi / 2021 / Cilt: 10 - Sayı: 2

5-HTT Geninin 5-HTTLPR (S) ve VNTR (10) Alel Kombinasyonlarının Adenotonsiller Hipertrofiye Karşı Koruyucu Etkisi

Protective Effect of 5-HTTLPR (S) and VNTR (10) Allele Combinationsof 5-HTT Gene Against Adenotonsillary Hypertrophy

Pages
6–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

TARTIŞMA ve SONUÇ: 5-HTT geninin S / S genotipi, 10 / S haplotipi ve 10/10 + S / S diplotipinin ATH’ye karşı koruyucu etkisi olabilir.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:GİRİŞ ve AMAÇ: 5HTT geni tarafından kodlanan serotonin taşıyıcı protein, serotoninin presinaptik geri alımından sorumludur.
📊
Key Findings & Data:Bu çalışmada pediatrik olgularda 5-HTT genindeki promotör (5-HTTLPR) ve ikinci intron (VNTR) bölgedeki polimorfizmler ile adenotonsiller hipertrofi (ATH) arasındaki ilişkiyi araştırdık.
💡
Conclusion & Impact:TARTIŞMA ve SONUÇ: 5-HTT geninin S / S genotipi, 10 / S haplotipi ve 10/10 + S / S diplotipinin ATH’ye karşı koruyucu etkisi olabilir.
🔬Design:Modeling & Simulation
📍Scope:119 hasta
⚙️Variables:Domain Parameters

Abstract

GİRİŞ ve AMAÇ: 5HTT geni tarafından kodlanan serotonin taşıyıcı protein, serotoninin presinaptik geri alımından sorumludur. Bu çalışmada pediatrik olgularda 5-HTT genindeki promotör (5-HTTLPR) ve ikinci intron (VNTR) bölgedeki polimorfizmler ile adenotonsiller hipertrofi (ATH) arasındaki ilişkiyi araştırdık. YÖNTEM ve GEREÇLER: 197 çocuğun 5-HTT gen promotor 5-HTTLPR ve intronic VNTR’si Snap Shot ile genotiplendirilerek, polimorfizmlerin birbiri ve fenotip arasındaki etkileşimler Çok Faktörlü Boyut Azaltma (Multifactor Dimensionality Reduction; MDR) programı ile analiz edildi. BULGULAR: Çalışmaya ATH tanısı almış 119 hasta (48 kız, 71 erkek yaş aralığı: 3-10 yıl; ortalama yaş: 5.38 yıl) ve 78 sağlıklı çocuk (27 kız, 51 erkek, yaş aralığı: 4-13 yıl; ortalama yaş: 6.76 yıl) dahil edildi. 5-HTTLPR (S) ve VNTR (10) allelinin tüm kalıtım modellerinde genotipik frekanslar açısından, ATH’li ile kontrol grubu arasında anlamlı bir fark gözlenmedi (tümü için P> 0.05). Bununla birlikte, 5-HTTLPR (S) allel ve VNTR_5-HTTLPR (10 / S) haplotip ve (10/10 + S / S) diplotipinin sıklığı ATH olgularına göre kontrol grubunda anlamlı olarak daha yüksekti (sırasıyla, P= 0.048, P = 0.041, P = 0.13). TARTIŞMA ve SONUÇ: 5-HTT geninin S / S genotipi, 10 / S haplotipi ve 10/10 + S / S diplotipinin ATH’ye karşı koruyucu etkisi olabilir.

Özet

INTRODUCTION: Serotonin transporter protein which is coded by 5HTT gene is responsible for presynaptic reuptake of serotonin. In this study, we investigated the relationship between polymorphisms in the promoter region (5-HTTLPR) and in the second intron (VNTR) in the 5-HTTgene and adenotonsillar hypertrophy (ATH) in pediatric cases. METHODS: Genotyped of the 5-HTT gene promotor 5-HTTLPR and intronic VNTR of in 197 children were analyzed using Snap Shot, Multifactor Dimensionality Reduction (MDR) software and carried out to assess the interactions among two polymorphisms and phenotype. RESULTS: A total of 119 children with ATH (48 girls, 71 boys age range: 3-10 years; mean age: 5.38 years) and 78 healthy children (27 girls, 51 boys, age range: 4-13 years; mean age: 6.76 years) were included in this study. The frequencies of the genotype in all of inheritance models of the 5-HTTLPR and the VNTR (10) allele showed no significant differences between ATH patient and healthy controls (for all P> 0.05). However, frequency of the 5-HTTLPR (S) allele and VNTR_5-HTTLPR (10/S) haplotype and (10/10+S/S) diplotype were significantly higher in the control group compared to ATH cases (P= 0.048, P= 0.041, P= 0.13). DISCUSSION AND CONCLUSION: In this study, we observed that S/S genotype, 10/S haplotype and 10/10 + S/S diplotype of 5-HTT gene could have protective effect against ATH.

🔖

Cite This Article

MUZ, S. E., ÖZDAŞ, S., ÖZDAŞ, T., ATİLLA, M. H., BAŞTİMUR, S., ÖZ, I., CANATAR, İ. (2021). 5-HTT Geninin 5-HTTLPR (S) ve VNTR (10) Alel Kombinasyonlarının Adenotonsiller Hipertrofiye Karşı Koruyucu Etkisi. Kocaeli Tıp Dergisi, Cilt: 10 - Sayı: 2, 6–15. https://ajindex.com/articles/413875

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Wysocka J, Hassmann E, Lipska A, Musiatowicz M. Naive and memory T cells in hypertrophied adenoids in children according to age. Int J Pediatr Otorhinolaryngol. 2003;67:237-241.
  2. Messner AH. Evaluation of obstructive sleep apnea by polysomnography prior to pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg. 1999;125:353-6.
  3. Modrzynski M, Zawisza E. An analysis of the incidence of adenoid hypertrophy in allergic children. Int J Pediatr Otorhinolaryngol. 2007; 1:713-9.
  4. Brodsky L. Adenotonsillar disease in children. Pract Paediatr Otolaryngol. 1999;2:15-39
  5. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I Affective Disorders Molecular Psychiatry. 2003;8:574-91.
  6. Shabaldina EV, Shabaldin AV,Riazantsev SV, Simbirtsev SV. The role of cytokine gene polymorphisms in the development of hypertrophy of the tonsils of the lymphoid pharyngeal ring and atopic march in the children.Vestn Otorinolaringol. 2013;6:18-23
  7. Ozdas S, Ozdas T, Acar M, Erbek SS, Koseoglu S, Gokturk G, Izbirak A. Association of Interleukin-10 gene promoter polymorphisms with obstructive sleep apnea. Sleep Breath. 2016;20:855-66.
  8. Xu H, Guan J, Yi H, Yin S. A systematic review and metaanalysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome. PloS ONE. 2014;9: e86460.
  9. Schroder CM, Primeau MM, Hallmayer JF, Lazzeroni LC, Hubbard JT, O’Hara R. Serotonin transporter polymorphism is associated with increased apnea-hypopnea index in older adults. International Journal of Geriatric Psychiatry. 2014;29:227-35.
  10. Lechin F, van der Dijs B, Orozco B, Lechin M, Lechin AE. Increased levels of free serotonin in plasma of symptomatic asthmatic patients. Ann Allergy Asthma Immunol. 1996;77:245-53.
  11. Veasey SC. Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential. Am J Respir Med. 2003;2:21-9.
  12. Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ, Darrow DH, Giordano T, Litman RS, Li KK et al. Clinical pra